Loop-mediated isothermal amplification (LAMP) is a novel, rapid nucleic acid amplification method with high specificity and sensitivity under isothermal conditions. In this study a LAMP assay for diagnosing Pneumocystis pneumonia (PCP) was developed. Oligonucleotide primers specific for Pneumocystis species were designed corresponding to 18S rRNA gene sequences. The assay, performed for 30 min at 61 6C, was capable of detecting 50 copies per tube (2¾10 3 copies ml "1 ) in 30 min and did not show cross-reactivity to other species of fungi, including the genera Candida, Aspergillus and Cryptococcus. A total of 21 of 24 clinical specimens (sputum and bronchoalveolar lavage fluid) from patients with suspected PCP tested positive using the LAMP assay by real-time fluorescence detection. The results of the LAMP reaction were also observed by real-time turbidity detection and end-point visual turbidity or fluorescence detection. With real-time fluorescence detection, melting curves of the products were effective at distinguishing specific amplification from non-specific amplification or self-amplification. Visual detection was also possible as a rapid and easy assay using only a heat block and a black light.
INTRODUCTION
Pneumocystis is a fungus belonging to the class Archiascomycetes, phylum Ascomycota. The human pathogen was known as Pneumocystis carinii f. sp. hominis, but has been renamed Pneumocystis jirovecii based on the results of molecular biological studies (Frenkel, 1999; Stringer et al., 2002) . This opportunistic fungus causes Pneumocystis pneumonia (PCP) in patients infected with human immunodeficiency virus (HIV), as well as other immunocompromised patients. Recently, human-tohuman transmission (Helweg-Larsen et al., 1998; Hocker et al., 2005) and colonization by P. jirovecii have been reported in the general population (Medrano et al., 2005) . Although the standard method for diagnosis of PCP is based on microscopic examination of clinical specimens [bronchoalveolar lavage fluid (BALF), sputum or lung biopsy], the sensitivity of this method is poor except in the hands of highly skilled examiners (Flori et al., 2004) . Therefore, PCR-based methods are widely used in Japan for the diagnosis of Pneumocystis infection. However, conventional PCR methods require a thermal cycler and electrophoresis for detection, whilst real-time PCR allows simultaneous amplification and detection, but requires expensive equipment and therefore is not available in general clinical laboratories.
strand-displacement activity. Specific nucleotide extension is achieved with four primers recognizing six distinct regions on the target. The amplification time can be further shortened by using an additional two primers, termed the loop primers (Nagamine et al., 2002) . Moreover, LAMP products can be detected not only using specialized equipment but also by visual observation of turbidity or fluorescence (Mori et al., 2001) . Here, we report the development of a Pneumocystis-specific LAMP assay, which has been applied successfully to clinical specimens for diagnosis of PCP.
METHODS
Fungal strains. A total of 69 strains from 51 species of fungi were used as controls in the present study (Table 1) .
Preparation of DNA from fungal cells. With the exception of P. jirovecii, all fungal strains were grown on Sabouraud dextrose agar [1 % (w/v) peptone; 1 % (w/v) glucose; 1.5 % (w/v) agar] at 27 or 37 uC for 1-5 days. Rapid preparation of DNA from the fungi was performed by a modification (Makimura et al., 1994 ) of a method described by Cenis (1992) . Briefly, small samples of mycelia grown on Sabouraud dextrose agar were placed in lysis buffer [200 mM Tris/ HCl (pH 8.0), 0.5 % (w/v) SDS, 250 mM NaCl, 25 mM EDTA] and crushed with a conical grinder. These samples were incubated at 100 uC for 15 min, mixed with 150 ml 3.0 M sodium acetate, kept at -20 uC for 10 min and then centrifuged at 10 000 g for 5 min. The supernatants were extracted once with phenol/chloroform/isoamyl alcohol (25 : 24 : 1, by vol.) and once with chloroform. DNA was precipitated with an equal volume of 2-propanol at -20 uC for 10 min, washed with 0.5 ml 99 % ethanol, dried and resuspended in 50 ml ultrapure water (MilliQ Synthesis A10; Millipore). Aliquots of 1 ml of the resulting solutions were used as templates for PCR.
DNA from yeasts was prepared by a modification of the method described by Makimura et al. (1994) . Briefly, small samples of individual yeast colonies were suspended in 100 ml lysis buffer. The samples were mixed using a vortex for 5 s and incubated at 100 uC for 15 min. Next, 100 ml 3.0 M sodium acetate was added and the preparations were mixed. After incubation at -20 uC for 10 min, the samples were centrifuged at 10 000 g for 5 min, after which the supernatants were transferred to fresh tubes. DNA was precipitated with an equal volume of 2-propanol, washed with 0.5 ml 99 % ethanol, dried and resuspended in 100 ml ultrapure water.
Clinical specimens. A total of 38 clinical specimens (24 from PCP and 14 from non-PCP patients) were examined. Twenty-four specimens, comprising eight sputum samples and sixteen BALF samples, were collected from twenty-one patients diagnosed with PCP and admitted to three hospitals in Tokyo (Social Insurance Central General Hospital, Tokyo Metropolitan Hiroo Hospital or the International Medical Center of Japan) between January 1998 and July 2006. In the PCP group (Table 2) , PCP was diagnosed by microscopic examination, or symptoms were improved by PCP therapy (co-trimoxazole, i.e. sulfamethoxazole/trimethoprim and/or pentamidine isethionate). In addition, 1 BALF sample and 13 bronchial lavage fluid (BLF) samples were collected from the 14 non-PCP patients (Table 3 ). The subjects in the non-PCP group, which comprised 1 patient with idiopathic pulmonary fibrosis and 13 with lung cancer, did not have fever or inflammatory signs. The PCP group included six patients with collagen disease (rheumatoid arthritis) treated with steroids or immunosuppressive agents, and one lung cancer patient treated with chemotherapy. The patients in the non-PCP group received no treatment with anti-Pneumocystis agents.
DNA preparation from clinical specimens. Clinical specimens were stored at -80 uC before DNA extraction using a NucliSENS kit manually with MiniMAG (bioMérieux) in accordance with the manufacturer's instructions. Samples of 200-1000 ml sputum, BALF or BLF were used for extraction and sample DNA was stocked at -80 uC before use.
Primer design. Oligonucleotide primers specific for the genus Pneumocystis were designed corresponding to regions of the 18S rRNA genes of P. jirovecii reported by Shah et al. (1996) and to genomic sequences determined in our laboratory. The following Archiascomycetes, Hemiascomycetes and human sequences were also used as references: P. carinii (host, ferret; GenBank accession no. S83267), P. carinii (host, rat; L27658), Pneumocystis murina (AY532651), P. carinii (X12708), Taphrina carnea (AB000948), Taphrina virginica (AB000960), Taphrina robinsoniana (AB000958), Taphrina nana (AB000955), Taphrina wiesneri (D12531), Taphrina communis (AB000949), Taphrina ulmi (AB000959), Schizosaccharomyces pombe (X58056), Candida albicans (E15168), Saccharomyces cerevisiae (Z75578) and Homo sapiens (M10098). Sequences were analysed using GENETYX software (Genetyx).
The sequences of our newly designed oligonucleotide PCR primers were as follows: 59-TTCGGGGCTTACTTTGGTC-39 (Pjf9), 59-GTAGTTAGTCTTCAATAAATCT-39 (Pjr4), 59-AGGCCTACCATG-GTTTCG-39 (Pjf8) and 59-CTTCGGAGGACCGGGCCGT-39 (Pjr8). In addition to these primers, the 18S rRNA gene-based universal fungal primers NS1, NS3, NS5, NS4, NS6 and NS8 (White et al., 1990) were also used for nested PCR and sequencing as shown in Fig. 1 .
As LAMP primers, a set of six oligonucleotides comprising two outer (F3 and B3), two inner (FIP and BIP) and two loop primers (FL and BL) recognizing eight distinct regions on the target sequence were designed using LAMP primer design support software (Primer Explorer version 3.0; Eiken Genome; http://primerexplorer.jp/). The FIP primer consisted of F2 and the complementary strand of F1 (F1c). The BIP primer consisted of B2 and the complementary strand of B1 (B1c). The sequences and positions of these primers are shown in Table 4 and Fig. 1 . All oligonucleotides were synthesized by Sigma-Aldrich.
PCR and plasmid preparation. Nested PCR was performed to amplify part of the 18S rRNA gene using primers NS1, NS8, Pjf9 and Pjr4. Each PCR mixture contained 10 ml 106 reaction buffer (GE Healthcare Bio-Sciences), 200 mM each dATP, dCTP, dGTP and dTTP (Toyobo), 2.5 U Taq polymerase (GE Healthcare Bio-Sciences), 30 pmol each primer and 1 ml DNA template solution. Ultrapure water was added to a final volume of 100 ml. First-round PCR was performed with primers NS1 and NS8 under the following conditions: 94 uC for 4 min; 30 cycles of 94 uC for 1 min, 55 uC for 2 min and 72 uC for 1.5 min; and 72 uC for 10 min. Secondround PCR was performed with primers Pjf9 and Pjr4 under the following conditions: 94 uC for 4 min; 25 cycles of 94 uC for 1 min, 60 uC for 15 s and 72 uC for 15 s; and 72 uC for 10 min. PCR products were separated by electrophoresis on 1.2 % agarose gels, stained with ethidium bromide and visualized by UV irradiation.
The PCR product amplified with the Pjf9 and Pjr4 primers was ligated into the TA cloning vector pCR 2.1 (Original TA cloning kit; Invitrogen). The ligated product was introduced into Escherichia coli DH5a (Nippon Gene) by transformation. After propagation and purification of the plasmid, the concentration (copies ml 21 ) was calculated from the measurement of A 260 and the molecular mass of the plasmid.
For nested PCR to detect P. jirovecii from clinical specimens, we used the Pneumocystis-specific primers Pjf9 and Pjr4 for first-round PCR and Pjf8 and Pjr8 for second-round PCR. The other PCR components were as described above. Both first-and second-round PCRs were performed under the following conditions: 94 uC for 4 min; 30 cycles of 94 uC for 1 min, 55 uC for 2 min and 72 uC for 1.5 min; and 72 uC for 10 min.
18S rRNA gene sequencing. The 18S rRNA gene DNA extracted from clinical sample number 1 (PCP group) was sequenced. Fig. 1 shows the location of the primers on the 18S rRNA gene. Both strands of the primary PCR product (generated with primers NS1 and NS8) were sequenced directly using an ABI PRISM BigDye terminator v1.1 cycle sequencing kit; Applied Biosystems) using primers NS1, NS3, NS4, NS5, NS6 and NS8 as reported by White et al. (1990) and an automated sequencer (ABI PRISM 310 genetic analyser; Applied Biosystems), in accordance with the manufacturer's instructions.
LAMP assay. The LAMP reaction was performed with a Loopamp DNA amplification kit (Eiken Chemical) in reaction mixtures composed of 40 pmol each of primers FIP and BIP, 5 pmol each of primers F3 and B3, 20 pmol each of primers FL and BL, 12.5 ml 26 reaction mixture, 1 ml Bst DNA polymerase, 2 ml DNA sample and distilled water up to a final volume of 25 ml. The mixtures were incubated at 61 uC for 30 min (Realoop-30; Eiken Chemical) or 60 min (LightCycler V3; Roche Diagnostics), and then heated at 80 uC for 2 min to terminate the reaction. When using the LightCycler, 20 mU Tth pyrophosphatase ml 21 (thermostable; Roche Diagnostics) and 0.25 mg YO-PRO1 ml 21 (a propidium dye; Molecular Probes) were added to the reaction mixtures. The temperature transition rate was 0.2 uC s 21 , increasing from 60 to 98 uC, and the cooling temperature was 30 uC for 1 min for melting curve analysis. For visual fluorescence detection, 1 ml fluorescent detection reagent (Eiken Chemical) was added to the reaction mixture. Control samples of plasmid solution (10 2 , 10 4 and 10 6 copies per tube, i.e. 4610 3 , 4610 5 and 4610 7 copies ml 21 , respectively) were checked each time.
Detection of LAMP products. LAMP products were detected by real-time fluorescence detection with a LightCycler, real-time turbidity detection with a Realoop-30, and end-point turbidity or visual fluorescence detection, the latter being judged under UV irradiation. When using the LightCycler, melting curves of the products were analysed and specific reactions were identified.
Sensitivity and specificity of the LAMP assay. The sensitivity of the LAMP assay was examined using serial dilutions of plasmid solution (1, 
RESULTS AND DISCUSSION

Specificity
A plasmid construct containing the nucleotide sequence of the 18S rRNA gene of P. jirovecii (GenBank accession no. AB266392) was amplified by the LAMP method. The experiment using LAMP primers for P. jirovecii did not show cross-reactivity with pathogenic or environmental fungi. DNA samples extracted from 69 strains of 51 species of fungi shown in Table 1 , including the genera Candida, Aspergillus and Cryptococcus, were not detected by the LAMP method.
Sensitivity
With a LAMP assay specific for Pneumocystis, it was possible specifically to detect Pneumocystis DNA in 30 min, with lower limits of detection of 50 or 100 copies (2610 3 or 4610 3 copies ml
21
) of template DNA using a LightCycler or by visual detection, respectively. Fig. 2 shows the results of real-time fluorescence detection using a LightCycler. DNA amplification is indicated by the rising curve of fluorescence in Fig. 2(a) . With the LAMP assay, it was possible to detect 100 copies per tube (4610 3 copies ml 21 ), with the curve beginning to rise at 12-13 min and reaching a plateau at 22-23 min. Detection of 50 copies per tube (2610 3 copies ml
) could be achieved in 30 min. In reactions of 10 copies per tube (4610 2 copies ml 21 ), products were detected in two out of three tubes, with no product detected in the remaining tube.
On visual detection, the results were judged at a reaction time of 30 min. By both visually determined turbidity and fluorescence detection, the assays could detect 100 copies of the target sequence per tube (4610 3 copies ml
). However, the results were unstable at concentrations below 50 copies per tube (2610 3 copies ml
). Fig. 3 shows the results of visual fluorescence detection (Fig. 3a) and turbidity detection (Fig. 3b) . 
Quantitative capability
The times to when fluorescence started rising and when it reached a plateau were short when there were high gene copy numbers in the tube. The graphs for each of the triplicate samples showed good accordance between P. jirovecii plasmid copy numbers of 2610 6 to 100 per tube (8610 7 to 4610 3 copies ml 21 ) (Fig. 2a) . However, there was no quantitative capability at template DNA copy numbers of less than 100 per tube (4610 3 copies ml
21
).
Melting-curve analysis
As shown in Fig. 2(b) , the melting curves of each sample were almost identical. This assay did not show a nonspecific reaction within 30 min; however, the reaction of some templates present at less than 10 copies per tube (400 copies ml
21
) for more than 30 min yielded melting-curve peaks that were different from those seen in the specific reactions. Non-specific reactions were observed using clinical specimens when the assay was continued for 1 h. However, the melting-curve peaks of non-specific reactions could be distinguished from those of specific reactions (Fig.  4) . Fig. 4 shows examples of the results of LAMP assays of PCP patients using a LightCycler. The melting curve of sample 12 gave a similar result to the positive control. One of the two distilled water samples and sample 13 showed non-specific reactions, and the peaks of their melting curves were different from those of the positive control.
In this study, we used melting-curve analysis rather than electrophoresis to distinguish specific LAMP products, as the process of agarose gel electrophoresis tends to cause severe contamination. There have been several recent reports of melting-curve analysis of PCR products (Bu et al., 2005; Haverstick et al., 2004; Shrestha et al., 2003) . PCR products can be characterized by melting-curve analysis because each double-stranded DNA molecule has a specific melting temperature (T m ) at which 50 % of the DNA becomes single-stranded. The T m value is dependent on both base sequence and GC content. Amplification of primer-dimers or non-specific products will be observed as peaks with different T m values. Bu et al. (2005) reported identification of PCR products amplified from Candida spp. and Aspergillus spp. using melting-curve analysis, and specific probes have been applied to melting-curve analysis typing of hepatitis virus (Haverstick et al., 2004) and differentiation of Mycobacterium species (Shrestha et al., 2003) . This is believed to be the first report of meltingcurve analysis of LAMP products. Identification of LAMP products may theoretically be determined by probes. However, as a relatively large number of oligonucleotides are already used, this would add to the complexity of this assay.
Clinical samples
A total of 22 samples (21 from PCP patients and 1 from a non-PCP subject) tested positive in the LAMP assay using the LightCycler (Tables 2 and 3 ). The diagnostic sensitivity of this assay was 87.5 % (21/24 PCP cases). In comparison, P. jirovecii DNA was detected in only 17 samples from PCP patients by nested PCR. The nested PCR used in the present study could detect 100 copies of plasmid per tube (10 3 copies ml 21 ) (data not shown) and the sensitivity of this method was 20 times lower than a quantitative realtime PCR reported by Brancart et al. (2005) . However, this nested PCR did not detect target DNA in any specimens from non-PCP cases or LAMP reaction-negative specimens. With regard to quantitative capability, we speculated that the target DNA copy number in sample 12 in Fig. 4(a , respectively) each time, and we estimated the equivalent DNA copy numbers of clinical specimens, as shown in Table 2 .
Only one patient (case 22) in the present study showed colonization with P. jirovecii. There have been a number of recent reports of P. jirovecii colonization in both the general population and in patients with respiratory disease (Maskell et al., 2003; Medrano et al., 2005; Vidal et al., 2006) , with colonization rates of about 20 % in healthy subjects (Medrano et al., 2005) and about 30 % in patients with interstitial lung disease (Vidal et al., 2006) . Further evaluation of this LAMP method with larger numbers of clinical specimens is currently under way in our laboratory. In the melting-curve analysis, the melting temperature of each sample is shown as a peak. Number of P. jirovecii plasmid copies: #, 2¾10 6 copies (8¾10 7 copies ml "1 ); $, 10 4 copies (4¾10 5 copies ml "1 ); h, 10 3 copies (4¾10 4 copies ml ); X, distilled water. LAMP method for Pneumocystis pneumonia diagnosis
Cost of the LAMP reaction
The LAMP reaction cost about J2.70 per test. Inclusion of the fluorescence detection reagent increased the cost to J3.20 per test. The costs were about the same as those of the PCR method. The LAMP method will be cheaper than the PCR method if visual detection without special equipment is used.
DNA extraction
In this study, we used a NucliSENS kit (bioMérieux) for extraction of P. jirovecii DNA, as described by Fischer et al. (2001) and Larsen et al. (2002) . This was completed in 1-2 h, generally with satisfactory results. However, simpler and easier methods of DNA extraction are necessary for clinical on-site application of this LAMP system. DNA extraction using this kit cost J4.50 per sample.
A method for extraction of P. jirovecii DNA using an FTA card (Whatman) has been reported (Jaijakul et al., 2005) . We attempted the LAMP assay with FTA cards for some specimens, but the results were not consistent (data not shown).
Advantage of the LAMP method
Visual detection is possible with the LAMP method (Fig. 3a) . A sensitive real-time PCR method capable of detecting 50 copies of target sequence ml 21 has been developed (Brancart et al., 2005) , although this system requires the use of specialized equipment. In contrast, amplification and visual detection of the LAMP reaction with a conventional incubator is a simple identification ). Negative control: X, distilled water.
N. Uemura and others method, although its sensitivity is slightly lower than that of the real-time PCR-based method. In patients with suspected PCP, this LAMP method is competent to diagnose PCP. Therefore, visual detection of the LAMP reaction is faster and easier than the PCR-based method and may be applied in general clinical laboratories.
